TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2020

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial.

Luis Paz-Ares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.